Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
HRMY Transcript
Harmony Biosciences Holdings, Inc. (HRMY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Neutral6-9
Harmony Biosciences Holdings, Inc. (HRMY) Q1 2026 Earnings Call Transcript
Positive5-7
The earnings call summary highlights strong financial performance and optimistic future guidance, particularly with WAKIX's blockbuster revenue projection and robust pipeline advancements. The Q&A session reveals management's strategic focus on expanding CNS indications and protecting IP, despite some uncertainties in litigation and business development. The market cap suggests moderate sensitivity to news, and the overall sentiment is positive, driven by promising product developments and strategic plans. The company's efforts to address analyst concerns and legal challenges indicate a proactive approach, supporting a positive stock price movement prediction.
Harmony Biosciences Holdings, Inc. (HRMY) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript
Neutral4-14
Harmony Biosciences Holdings, Inc. (HRMY) Q4 2025 Earnings Call Transcript
Positive2-24
The earnings call reflects strong financial health and strategic growth, with raised revenue guidance and successful product developments. Despite competitive pressures and litigation uncertainties, the company maintains robust cash reserves. The Q&A section highlights a proactive approach to potential risks, with strategic settlements and ongoing R&D investments. The raised revenue guidance and strategic pipeline advancements contribute to a positive outlook, likely resulting in a 2-8% stock price increase.
HRMY Slides
HRMY Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
